Received
Friday, December 17, 2021
Commodity
Adalimumab, Processes for Manufacturing or Relating to Same, and Products Containing Same
Investigation Number
337-TA-1296
Filed By
Mareesa A. Frederick
Firm/Organization
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Behalf Of
AbbVie Inc., AbbVie Biotechnology Ltd, and AbbVie Operations Singapore Pte. Ltd.
Confidential
Yes
Country
None
Description
Letter to Lisa R. Barton, Secretary, USITC; requesting that the Commission conduct an investigation under section 337 of the Tariff Act of 1930, as amended, in the matter of certain adalimumab, processes for manufacturing or relating to same, and products containing same. The proposed respondents are Alvotech hf., Iceland; Alvotech Germany GmbH, Germany; Alvotech Swiss AG, Switzerland; Alvotech USA Inc., Arlington, VA; Teva Pharmaceutical Industries Ltd., Israel; Teva Pharmaceuticals USA Inc., North Wales, PA; and Ivers-Lee AG, Switzerland.
Petition/Complaint Status
Instituted